Vascular Closure Device Market Size - By Device Type (Active Vascular Closure Devices {Suture-mediated Devices, Staple/Clip-mediated Vascular Closure Devices, Collagen Plug-mediated Devices}, Passive Vascular Closure Devices), By Access (Femoral, Radial), By End-use, Forecast, 2023 – 2032.

Vascular Closure Device Market Size

Vascular Closure Device Market size was worth USD 1.5 billion in 2022 and is estimated to grow at 6.5% CAGR from 2023 to 2032 driven by the rapidly expanding geriatric patient pool worldwide.

The rising number of people suffering from cardiovascular diseases will favor the market growth. According to the CDC estimates, cardiovascular disease results in 1 out of every 5 deaths in the U.S.  The surge in cardiovascular ailments has made way for increasing number of vascular catheterization procedures, in turn will driving the demand for vascular closure devices. The surging incidences of myocardial infarction, valvular diseases, and congenital heart diseases along with the adoption of angiographic procedures for reduced bleeding and faster homeostasis will accelerate the market trends.

The rising concerns regarding the increasing risks associated with the vascular closure devices during and after treatment may slow down the market expansion to some extent. Suture-mediated devices, for instance, can pose dangers, such as retroperitoneal hemorrhage, hematoma, pseudoaneurysm, and arteriovenous fistula. Local bleeding, arterial leg ischemia, and infections are further risks associated with these devices. Hence, the declining patient preference from pursuing surgeries incorporating such devices may reduce the product adoption.

COVID-19 Impact

The COVID-19 outbreak negatively impacted the vascular closure devices market revenue in 2020 considering that hospitals and other healthcare institutions were constantly engaged in the treatment of the coronavirus-affected patients due to rapidly increasing infection rate worldwide. The rising frequency and fatality rate led to the declining need for other therapeutic procedures at healthcare institutions. Furthermore, the declaration of national emergencies and prohibitions by many countries on all elective surgical operations in outpatient and inpatient settings also restricted the market development.

Vascular Closure Device Market Trends

Several technical breakthroughs to increase the efficacy of vascular closure devices for enhanced safety and patient comfort will accelerate the market demand. The demand for biodegradable closure devices has gained widespread popularity due to their composition of biodegradable materials and gradual disintegration for natural healing. Furthermore, the growing demand for topical hemostatic medicines in conjunction with closure devices to improve hemostasis will drive the market expansion.

Vascular Closure Device Market Analysis

Based on device type, the active vascular closure devices market is expected to witness tremendous growth and reach USD 1.8 billion by 2032 attributed to the rising patient inclination towards minimally invasive procedures in interventional radiology and cardiology. Active vascular closure devices (AVCDs) provide quicker hemostasis compared to traditional manual compression techniques, allowing patients to ambulate earlier and recover faster with enhanced turnover and optimized resources. Furthermore, AVCDs, when compared to manual compression therapy, provide more comfortable experiences for patients along with less discomfort and shorter recovery time, further driving the segment growth.

In terms of end-use, the hospitals segment accounted for 60% revenue share of the vascular closure device market in 2022 and is estimated to expand at notable pace between 2023 and 2032. The growth can be attributed to their rising preference due to the presence of dedicated cardiovascular facilities, such as cardiac catheterization labs, operating rooms, and ICUs for managing complex cardiovascular treatments and offering required technologies and resources. The availability of modern diagnostic tools and imaging technology along with highly qualified and experienced healthcare workers for better treatment to patients will also favor the segment expansion.
 

North America held dominant share of the vascular closure device market accounting for more than USD 689 million in revenue in 2022 and is projected to witness steady growth through 2032 due to the high incidence of cardiovascular illnesses in the region. The growing elderly population base susceptible to cardiovascular diseases has led to the higher availability of cutting-edge healthcare infrastructure. Furthermore, the presence of reimbursement coverage for medical operations encouraging healthcare professionals and patients to opt for innovative treatment alternatives will drive the market development.

Vascular Closure Device Market Share

Some of the major players operating in the vascular closure device market include

• Scion BioMedical
• Abbott
• Terumo Corporation
• Cardinal Health, Inc.
• Medtronic plc
• Teleflex Incorporated
• TZ Medical
• Tricol Biomedical
• Advanced Vascular Dynamics
• Cardiva Medical Inc.
• Marine Polymer Technologies
   

Vascular Closure Device Industry News

• In May 2022, Teleflex Incorporated revealed that its MANTA Vascular Closure Device received approval from Health Canada as the only commercially available biomechanical vascular closure equipment in large-bore femoral arterial access site closure.

   

   

Vascular closure device market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) and volume (Units) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Device Type, 2018 - 2032 (USD Million & Units)

• Active vascular closure devices
  •   Suture-mediated devices            
  • Staple clips-mediated vascular closure devices
  • Collagen plug-mediated devices
• Passive vascular closure devices
  •   Haemostasis pads/patches
  •   Compression devices

By Access, 2018 - 2032 (USD Million)

• Femoral
• Radial

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Ambulatory Surgical Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Peru
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Israel
  • Iran